Similar Stocks: SciClone Pharmaceuticals

Obermatt gives you highly-ranked stock ideas that are similar to the stock you're analyzing.

Stocks Similar to n/a

These alternatives to SciClone Pharmaceuticals fall within a similar industry. Our selection might include stock ideas that will surprise you.

Name
360° View
Sentiment
Combined
Value
1.
XL • Biotechnology
93
14
20
14
2.
XXL • Pharmaceuticals
59
14
20
14
3.
XXL • Life Sciences Tools & Services
89
14
20
14
4.
XXL • Pharmaceuticals
50
14
20
14
5.
XXL • Pharmaceuticals
49
14
20
14
6.
XXL • Pharmaceuticals
56
14
20
14
7.
XXL • Biotechnology
48
14
20
14
8.
XXL • Life Sciences Tools & Services
65
14
20
14
9.
XXL • Pharmaceuticals
33
14
20
14
10.
XL • Life Sciences Tools & Services
18
14
20
14
Unlock
Unlock five additional ranks for full insights
1.
XL • Biotechnology
93
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
2.
XXL • Pharmaceuticals
59
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
3.
XXL • Life Sciences Tools & Services
89
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
4.
XXL • Pharmaceuticals
50
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
5.
XXL • Pharmaceuticals
49
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
6.
XXL • Pharmaceuticals
56
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
7.
XXL • Biotechnology
48
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
8.
XXL • Life Sciences Tools & Services
65
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
9.
XXL • Pharmaceuticals
33
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety
10.
XL • Life Sciences Tools & Services
18
360° View
10
Sentiment
40
Combined
97
Value
97
Growth
97
Safety

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.